IL-17 in cutaneous lupus erythematosus

European Journal of Internal Medicine

Volumn 21, Issue 3, 2010, Pages 202-207

  Tanasescu, C ^a   Balanescu, E ^a   Balanescu, P ^a   Olteanu, R ^a   Badea, C ^a   Grancea, C ^b   Vagu, C ^b   Bleotu, C ^b   Ardeleanu, C ^c   Georgescu, A ^c  

^a Carol Davila School of Medicine   (Romania)

^b STEFAN S NICOLAU INSTITUTE OF VIROLOGY   (Romania)

^c NATIONAL INSTITUTE FOR RESEARCH AND DEVELOPMENT IN MICROTECHNOLOGIES   (Romania)

Author keywords

Cutaneous lupus erythematosus; IL 17A; IL 17F; Th17

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 23;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; PSORIASIS; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIGENS, CD4; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; INTERLEUKINS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, DISCOID; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTES; MALE; MIDDLE AGED; PSORIASIS; SKIN;

EID: 77952291147     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.03.004     Document Type: Article

References (20)

1. Heinlen L.D., McClain M.T., Merrill J., Akbarali Y.W., Edgerton C.C., Harley J.B., et al. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum 56 (2007) 2344-2351
2. Bohm M., Luger T.A., Schneider M., Schwartz T., and Kuhn A. New insight into immunosupression and treatment of autoimmune diseases. Clin Exp Rheumatol 24 (2006) 67-71
3. Stockinger B., and Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 19 (2007) 281-286
4. van Beelen A. J., Teunissen M., Kapsenberg M., and Jong E. Interleukin-17 in inflammatory skin disorders: IL-17 and immune pathology in the skin. Curr Opin Allergy Clin Immunol 7 5 (2007) 374-381
5. Kobayashi K., Takahashi N., Jimi E., Udagawa N., Takami M., Kotake S., et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103 (1999) 1345-1352
6. Tzartos S., Friese M., Craner M., Palace J., Newcombe J., and Esiri M.M. IL-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 172 (2008) 146-154
7. Tan E.M., Cohen A.S., Fries J.F., Masi T., McShane N.F., Rothfield J.G., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
8. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., and Chang C.H. The Committee on Prognosis Studies in SLE, derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35 (1992) 630-640
9. Callen J.P., and Klein J. Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients. Arthritis Rheum 31 8 (Aug 1988) 1007-1013
10. Millns A., and Sigfried A. The coexistence of psoriasis and lupus erythematosus. Arch Dermatol 116 6 (1980) 658-663
11. Di Cesare A., Di Meglio P., and Nestle F.P. The Il-23/Th17 axis in immunopathogenesis of psoriasis. J Invest Dermatol 129 6 (2009) 1339-1350
12. Louten J., Bonifacek K., and Malefyt de.W. Development and function of TH17 cells in health and disease. J of Allergy and Clin Immunol 123 5 (2009) 1004-1011
13. Liang S., Tan X., Luxemberg D., Karim R., Dunussi-Joannopoulos K., Collins M., et al. IL-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 (2006) 2271-2279
14. Osorio F., Landmann S., Lochner M., Lahl K., Sparwasser T., Eberl G., et al. DC activated via dectin-1 convert T-reg into IL-17 producers. Eur J Immunol 38 (2008) 3274-3281
15. Nograles K.E., Zaba L.C., Guttman-Yassky E., Fuentes-Duculan J., Suárez-Fariñas M., Cardinale I., et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159 5 (2008) 1092-1102 Nov
16. Montoya M., Schiavoni G., Mattei F., Gresser I., Belardelli F., Borrow P., et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99 9 (2002) 3263-3271
17. Johansen C., Usher P.A., Kjellerup R.B., Lundsgaard D., Iversen L., and Kragballe K. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol 160 2 (2009) 319-324
18. Pan H., Zhao X., Yuan H., Zhang W., Li X., Wang G., et al. Decreased serum IL-22 levels in patients with systemic lupus erythematosus. Clin Chim Acta 401 1 (2009) 179-180
19. Wong C.K., Lit L.C.W., Tam L.S., Li E.K.M., Wong P.T.Y., and Lam C.W.K. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th-17 inflammation in autoimmunity. Clin Immunol 127 (2008) 385-393
20. Chen Z., Tato C., Muul L., Laurence A., and O'Shea J. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 56 (2007) 2936-2946